Literature DB >> 12522608

Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles.

Christopher J Harvey1, Adrian K P Lim, Martin J K Blomley, Simon D Taylor-Robinson, Wladyslaw M W Gedroyc, David O Cosgrove.   

Abstract

The radiological surveillance of cirrhosis to detect the development of hepatocellular carcinoma (HCC) is problematic because no highly sensitive and specific imaging investigation is available. Ultrasound is typically the first modality used but is less accurate than other imaging modalities. We report the first case of a patient with cirrhosis in whom US imaging with liver-specific microbubbles detected an HCC prior to its detection by MR. The use of liver-specific microbubble US contrast agents is an exciting development in the detection of HCC in chronic liver disease and may help to rectify some of the shortcomings of US.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12522608     DOI: 10.1007/s00330-002-1593-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  5 in total

Review 1.  Ultrasound imaging beyond the vasculature with new generation contrast agents.

Authors:  Reshani H Perera; Christopher Hernandez; Haoyan Zhou; Pavan Kota; Alan Burke; Agata A Exner
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-08

2.  Clinicoradiologic and sonographic patterns of metastasis in hepatocellular carcinoma.

Authors:  Jesse A Otegbayo; Omolola M Atalabi; Abdulmumini Yakubu
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

3.  Acute heart failure caused by a giant hepatocellular metastatic tumor of the right atrium.

Authors:  Panagiotis Dedeilias; Ioannis Nenekidis; Ioannis Koukis; Vania Anagnostakou; Niki Paparizou; Spyros Zompolos; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2011-08-26       Impact factor: 1.637

4.  Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.

Authors:  A K P Lim; S D Taylor-Robinson; N Patel; R J Eckersley; R D Goldin; G Hamilton; G R Foster; H C Thomas; D O Cosgrove; M J K Blomley
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

5.  Hepatocellular carcinoma - issues in imaging.

Authors:  C H Thng; Y T Kuo
Journal:  Cancer Imaging       Date:  2004-10-20       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.